NURIX THERAPEUTICS INC
NRIXNASDAQ🏆 #1532 by market capEarnings Oct 7US Equity
$25.96▲ $0.08 (+0.31%)
🌅 Pre-market$26.55▲ 2.27%Regular close · extended-hours price shown1h—
24h▲ 0.3%
7d▲ 3.3%
14d▲ 10.1%
30d▲ 14.2%
1y▲ 159.3%
🏦Market Cap
$2.69B
Small Cap
📈Revenue Growth (YoY)
-58.4%
Declining
📊Gross Margin
—
💵FCF Margin
65.6%
Strong
⚖️P/S Ratio
73.1x
Expensive
Otter Score
64
Fair
📊
Analyst Ratings
Price
$25.96
Total
19
Raised
0
Lowered
0
Avg PT
$34.67
H / L
$45 / $28
| Institution | Action | Rating | Date |
|---|---|---|---|
Morgan Stanley | Reiterated | Overweight | 2026-07-28 |
UBS | Reiterated | Buy | 2026-07-22 |
Mizuho | Reiterated | Outperform | 2026-07-13 |
HC Wainwright & Co. | Reiterated | Buy | 2026-07-10 |
BTIG | Reiterated | Buy | 2026-07-10 |
Truist Securities | Reiterated | Buy | 2026-07-10 |
RBC Capital | Reiterated | Outperform | 2026-07-10 |
Needham | Reiterated | Buy | 2026-07-10 |
Stifel | Reiterated | Buy | 2026-07-10 |
Baird | Reiterated | Outperform | 2026-06-18 |
Jefferies | Reiterated | Buy | 2026-06-08 |
Wells Fargo | Reiterated | Overweight | 2026-06-08 |
Piper Sandler | Reiterated | Overweight | 2026-01-29 |
Oppenheimer | Reiterated | Outperform | 2025-10-10 |
Stephens & Co. | Reiterated | Overweight | 2025-07-10 |
JP Morgan | Reiterated | Overweight | 2025-01-29 |
Barclays | Reiterated | Overweight | 2024-07-15 |
SVB Leerink | Reiterated | Outperform | 2022-12-13 |
Berenberg | Reiterated | Buy | 2021-04-14 |
One row per institution, most recent rating